ONCS - OncoSec Medical Inc
Previous close
0.2772
0 0%
Share volume: 52,491,052
Last Updated: Fri 23 Jun 2023 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.28
0.00
0.00%
Summary score
42%
Profitability
50%
Dept financing
9%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-67.66%
Return on assets
-31.41%
Return on sales
0%
Return on invested capital
39.07%
Total debt ratio
25.85%
Debt ratio change over timeo
-0.92%
Current Ratio
5.49%
Quick Ratio
0%
Cash Position Ratio
4.12%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-164.28%
Return on assets
-39.7%
Return on sales
0%
Return on invested capital
289.76%
Total debt ratio
41.43%
Debt ratio change over timeo
-0.79%
Current Ratio
3.98%
Quick Ratio
0%
Cash Position Ratio
3.44%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-429.43%
Return on assets
-68.33%
Return on sales
0%
Return on invested capital
469.95%
Total debt ratio
83.96%
Debt ratio change over time
-0.6%
Current Ratio
1.16%
Quick Ratio
0%
Cash Position Ratio
0.88%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-123.84%
Return on assets
-107.84%
Return on sales
0%
Return on invested capital
-35.2%
Total debt ratio
-92.47%
Debt ratio change over time
-0.92%
Current Ratio
0.14%
Quick Ratio
0%
Cash Position Ratio
-0.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ONCS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -67.66% | 0% | 0% | 32.94% |
| Return on assets | -31.41% | 0% | 0% | -9.88% |
| Return on sales | 0% | 0% | 0% | -1451.74% |
| Return on invested capital | 39.07% | 0% | 0% | 38.19% |
| Profitability | 50% | 0% | 25% | 49% |
| Total debt ratio | 25.85% | 0% | 0% | 191.06% |
| Debt ratio change over time | -0.92% | 0% | 0% | 20.42% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 3.98% | 0% | 0% | 3.57% |
| Quick Ratio | 0% | 0% | 0% | 3.57% |
| Cash Position Ratio | 3.44% | 0% | 0% | 3.48% |
| Liquididy | 50% | 0% | 0% | 60% |
| Short-term ratios | ONCS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -164.28% | 0% | 0% | 16.85% |
| Return on assets | -39.7% | 0% | 0% | -15.81% |
| Return on sales | 0% | 0% | 0% | -3194.77% |
| Return on invested capital | 289.76% | 0% | 0% | 64.42% |
| Profitability | 50% | 0% | 25% | 31% |
| Total debt ratio | 41.43% | 0% | 0% | 91.27% |
| Debt ratio change over time | -0.79% | 0% | 0% | 0.42% |
| Dept financing | 11% | 0% | 0% | 50% |
| Current Ratio | 3.98% | 0% | 0% | 3.57% |
| Quick Ratio | 0% | 0% | 0% | 3.57% |
| Cash Position Ratio | 3.44% | 0% | 0% | 3.48% |
| Liquididy | 50% | 0% | 0% | 72% |